Furthermore, the specialized proresolving mediator maresin-1 has been shown to reduce asthma-associated bronchial inflammation in a murine model, and this was associated with an increased expression of amphiregulin and de novo generation of CD4+ Tregs (68). Here, AREG is linked to asthma.